Literature DB >> 3106502

A new assay for interleukin-1 in the presence of interleukin-2.

W Falk, P H Krammer, D N Männel.   

Abstract

A simple and reliable assay for interleukin-1 (IL-1) is described which has the advantage over other assays that it is independent of interleukin-2 (IL-2) production by the test cells. The assay makes possible the detection of IL-1 in the supernatants of T cell populations. The ability of IL-1 to induce IL-2 receptor expression in the absence of T cell mitogen is the basis of this assay. Thus, proliferation of mouse thymocytes incubated in the presence of saturating concentrations of IL-2 (10 U/ml) was directly dependent on the concentration of IL-1. The sensitivity of the assay is comparable to the sensitivity of the classical thymocyte co-stimulator assay. Natural and recombinant human and murine IL-1 were measured in this test system with comparable sensitivity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106502     DOI: 10.1016/0022-1759(87)90030-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Production of an interleukin-1 inhibitor by cell line P388D1 murine macrophages stimulated with Haemophilus actinomycetemcomitans lipopolysaccharide.

Authors:  T Nishihara; T Koga; S Hamada
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

2.  In vitro modulation of keratinocyte-derived interleukin-1 alpha (IL-1 alpha) and peripheral blood mononuclear cell-derived IL-1 beta release in response to cutaneous commensal microorganisms.

Authors:  C E Walters; E Ingham; E A Eady; J H Cove; J N Kearney; W J Cunliffe
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

3.  Pathogenesis of porcine Actinobacillus pleuropneumonia, part II: roles of proinflammatory cytokines.

Authors:  H Huang; A A Potter; M Campos; F A Leighton; P J Willson; D M Haines; W D Yates
Journal:  Can J Vet Res       Date:  1999-01       Impact factor: 1.310

4.  A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice.

Authors:  H R Alexander; G M Doherty; C M Buresh; D J Venzon; J A Norton
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.